Showing results (321-330 of 401) with videos related to
Sort By:
Pageof 41
Journal for Immunotherapy of Cancer|December 18, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse eventsMarcela V Maus, Sara Alexander, Michael R Bishop, et al.Blood|September 15, 2021
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cellsDaniel A Lichtenstein, Fiorella Schischlik, Lipei Shao, et al.Bone Marrow Transplantation|November 5, 2023
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trialKarl-Walter Sykora, Rita Beier, Ansgar Schulz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 6, 2016
Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow TransplantationGiovanna Lucchini, Myriam Labopin, Eric Beohou, et al.Bone Marrow Transplantation|December 12, 2018
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted settingAttilio Bondanza, Loredana Ruggeri, Maddalena Noviello, et al.Blood Advances|April 29, 2020
Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemiaBrigitte Strahm, Felicia Loewecke, Charlotte M Niemeyer, et al.Blood Advances|November 9, 2022
Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic useDaniela Weber, Markus Weber, Elisabeth Meedt, et al.American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.Journal of Translational Medicine|November 22, 2023
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host diseaseHalvard Bonig, Mareike Verbeek, Peter Herhaus, et al.Haematologica|August 18, 2025
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM TrialAdriana Balduzzi, Evgenia Glogova, Christina Peters, et al.Pageof 41